tiprankstipranks
Atara Biotherapeutics remains eligible for $60M milestone payment
PremiumThe FlyAtara Biotherapeutics remains eligible for $60M milestone payment
6d ago
Atara announces Ebvallo CRL did not find clinical efficacy deficiencies
Premium
The Fly
Atara announces Ebvallo CRL did not find clinical efficacy deficiencies
6d ago
Atara Biotherapeutics expands review of strategic alternatives for CAR-T assets
Premium
The Fly
Atara Biotherapeutics expands review of strategic alternatives for CAR-T assets
6d ago
Atara Biotherapeutics price target raised to $21 from $13 at Canaccord
PremiumThe FlyAtara Biotherapeutics price target raised to $21 from $13 at Canaccord
2M ago
Atara Biotherapeutics Advances with Strategic Partnerships
Premium
Company Announcements
Atara Biotherapeutics Advances with Strategic Partnerships
2M ago
Atara Biotherapeutics reports Q3 EPS ($2.93), consensus ($1.93)
Premium
The Fly
Atara Biotherapeutics reports Q3 EPS ($2.93), consensus ($1.93)
2M ago
Atara Biotherapeutics Announces Board Appointment and Capital Raise
PremiumCompany AnnouncementsAtara Biotherapeutics Announces Board Appointment and Capital Raise
5M ago
Atara Biotherapeutics announces $36M registered direct offering
Premium
The Fly
Atara Biotherapeutics announces $36M registered direct offering
5M ago
Mizuho upgrades Atara to Buy into potentially better 2025
Premium
The Fly
Mizuho upgrades Atara to Buy into potentially better 2025
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100